echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > A high-risk and high-return method for the treatment of frostbite

    A high-risk and high-return method for the treatment of frostbite

    • Last Update: 2021-10-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Neuroscientists say that it is time to implement the moon landing plan for ALS patients


    Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease (Lou Gehrig's disease), deprives people of their mobility and ultimately their breathing


    Now, the National Institutes of Health has funded a $3.


    Stuart Batterman, co-principal researcher at the University of Michigan School of Public Health, said that a bold design is needed to put environmental exposures in the most important position, such as pesticides, metals, industrial chemicals, air pollution and air.


    Batman, a professor of environmental health sciences, global public health, and civil and environmental engineering at the University of Michigan, said: "There are so many potential environmental toxins that it is difficult to determine which are important without a comprehensive approach


    "We need to understand the mechanisms by which these exposures lead to disease so that we can develop personalized treatments based on the individual's previous exposure," said Stephen Pranger, director of the Prager ALS Clinic and associate professor of neurology.


     "In addition, once we have a better understanding of the environmental mechanisms that lead to ALS, we hope to reduce people's exposure to these incentives, so as to prevent people from developing ALS in the future


    Goutman said that the combination of new treatment goals and public health prevention strategies is the ultimate goal of this four-year project


    "Given that we see more and more ALS patients every year, there is no better time than now to initiate these important investigations," said lead researcher Eva Feldman


    Researchers will compare the blood samples of 400 ALS patients with the blood samples of 200 non-ALS study participants.


    "Considering the recent advances in sequencing and computational methods in integrating large amounts of heterogeneous multiple sets of data, the time for this work is ripe," said co-principal researcher Maureen Sartor, a Computational Medicine, Bioinformatics and Bioinformatics Institute at the School of Public Health.


    Feldman said: "ALS is a devastating disease for our patients and their loved ones


    This project is one of four recent frostbite projects funded by the National Institutes of Health.


    Talking about the project, Francis Collins, director of the National Institutes of Health, said: "The scientific research proposed by this research group is very novel and creative, and will definitely break the known boundaries


     



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.